This was achieved by a reduction in VLDL-TG production rate ( PR ) compared with placebo ( -@ % , p = @ ) or ATV ( -@ % , p = @ ) as well as a reciprocal increase in VLDL-TG FCR ( +@ % , p < @ ) compared with placebo .